• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.67% Nasdaq Up1.47%

    Northwest Biotherapeutics, Inc. (NWBO)

    -NasdaqCM
    8.27 Up 0.42(5.35%) 4:00PM EDT
    |After Hours : 8.27 0.00 (0.00%) 4:36PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 1,454   809   772  
    Cost of Revenue -   -   -  
    Gross Profit 1,454   809   772  
    Operating Expenses
    Research Development85,637  43,906  28,908  
    Selling General and Administrative16,949  12,365  15,675  
    Non Recurring -   -   -  
    Others11  12  14  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (101,143) (55,474) (43,825)
    Income from Continuing Operations
    Total Other Income/Expenses Net(33,495)(9,473)(10,053)
    Earnings Before Interest And Taxes(134,638)(64,947)(53,878)
    Interest Expense996  842  13,442  
    Income Before Tax(135,634)(65,789)(67,320)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(135,634)(65,789)(67,320)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (135,634) (65,789) (67,320)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (135,634) (65,789) (67,320)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.